Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >

Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca

November 08, 2024

Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity

October 31, 2024

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

October 30, 2024

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

October 24, 2024

Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'

October 23, 2024

Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use

October 23, 2024

Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

October 23, 2024

Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034

October 15, 2024

Cramer's Lightning Round: Uranium Energy is 'the real deal'

October 14, 2024

Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says

October 11, 2024

Ozempic underworld: Inside the black market of obesity drugs

October 09, 2024

CNBC Daily Open: October’s gravity bringing stocks down

October 04, 2024

Friday's big stock stories: What’s likely to move the market in the next trading session

October 03, 2024

Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown

October 01, 2024

East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade

October 01, 2024

Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says

September 25, 2024

5 things to know before the stock market opens Wednesday

September 25, 2024

Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next

September 24, 2024

Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices

September 24, 2024

Tuesday's big stock stories: What's likely to move the market in the next trading session

September 23, 2024

Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100

September 22, 2024

FTC sues drug middlemen for allegedly inflating insulin prices

September 20, 2024

Novartis not joining the 'frenzy' of weight loss drugs, CEO says

September 18, 2024

Healthy Returns: How competitive can Roche be in the weight loss drug market?

September 17, 2024

How the Research Triangle has helped make North Carolina one of America's fastest-growing economies

September 16, 2024

CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain

September 12, 2024

Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs

September 12, 2024

Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs

September 10, 2024

Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock

September 05, 2024

5 things to know before the stock market opens Tuesday

September 03, 2024

< Previous 1 2 3 4 5 6 7 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.